New Zealand markets open in 4 hours 2 minutes

MRNA Jan 2024 260.000 put

OPR - OPR Delayed price. Currency in USD
Add to watchlist
142.850.00 (0.00%)
As of 03:47PM EDT. Market open.
Full screen
Previous close142.85
Open142.85
Bid153.65
Ask159.55
Strike260.00
Expiry date2024-01-19
Day's range142.85 - 142.85
Contract rangeN/A
Volume3
Open interestN/A
  • Motley Fool

    Moderna's Shares Could Take Off if These 2 Things Happen

    Moderna (NASDAQ: MRNA) used to be a stock market star, climbing 1,700% from the start of 2020 through July of 2021. Investors liked that, and it clearly showed in the stock performance. After all, the vaccine is Moderna's only product right now, and demand for it has declined.

  • Motley Fool

    Here's Why You Should Consider Moderna Stock, and No, It's Not the COVID Vaccine

    Once a relatively unknown biotech company, Moderna (NASDAQ: MRNA) became a household name when it became one of the first companies to offer a vaccine for the COVID-19 virus. At its peak, Moderna saw quarterly revenue of $7 billion as it sold vaccines to the world. Its stock price followed suit, reaching an all-time high of $484 in mid-2021.

  • Motley Fool

    If I Could Only Buy 3 Stocks in 2023, I'd Pick These

    CRISPR Therapeutics (NASDAQ: CRSP) specializes in gene editing, or the repair of faulty genes responsible for disease. Right now, CRISPR is heading for its biggest moment ever -- a regulatory decision on what may become its first commercialized product. The U.S. Food and Drug Administration (FDA) is set to decide on exa-cel for sickle cell disease in December and on exa-cel for beta thalassemia in March.